Deep gray matter volume loss drives disability worsening in multiple sclerosisArman Eshaghi, Ferrán Prados, Wallace Brownlee et al.|Annals of Neurology|2018Cited by 441
Diagnosis of multiple sclerosis: 2024 revisions of the McDonald criteriaXavier Montalbán, Heinz Wiendl, Christine Lebrun‐Frénay et al.|The Lancet Neurology|2025Cited by 314
Conversion from clinically isolated syndrome to multiple sclerosis: A large multicentre studyJens Kühle, A. Martinez, Giulio Disanto et al.|Multiple Sclerosis Journal|2015Cited by 298
PML in a Patient Treated with Dimethyl Fumarate from a Compounding PharmacyBob W. van Oosten, Mike P. Wattjes, Joep Killestein et al.|New England Journal of Medicine|2013Cited by 184
NLRP3 inflammasome is associated with the response to IFN-β in patients with multiple sclerosisSunny Malhotra, Manuel Comabella, Jordi Río et al.|Brain|2015Cited by 110